Phagotherapy, the use of bacteriophages to fight bacterial infections as an alternative to antibiotic treatments, has become of increasing interest in the last years. This is mainly due to the diffusion of multi-drug resistant (MDR) bacterial infections that constitute a serious issue for public health. Phage therapy is gaining favor due to its success in agriculture and veterinary treatments and its extensive utilization for human therapeutic protocols in the Eastern world. In the last decades, some clinical trials and compassionate treatments have also been performed in the Western world, indicating that phage therapy is getting closer to its introduction in standard therapy protocols. However, several questions concerning the use of phages in human therapeutic treatments are still present and need to be addressed. In this review, we illustrate the state of art of phage therapy and examine the role of animal models to translate these treatments to humans.
Animal Models to Translate Phage Therapy to Human Medicine / A. Brix, M. Cafora, M. Aureli, A.S. Pistocchi. - In: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. - ISSN 1661-6596. - 21:10(2020 May 25).
|Titolo:||Animal Models to Translate Phage Therapy to Human Medicine|
CAFORA, MARCO (Secondo) [Membro del Collaboration Group]
AURELI, MASSIMO (Penultimo) [Membro del Collaboration Group]
PISTOCCHI, ANNA SILVIA (Ultimo) [Membro del Collaboration Group] (Corresponding)
|Parole Chiave:||phage therapy; bacteria; animal models; immune system; antibiotics|
|Settore Scientifico Disciplinare:||Settore BIO/13 - Biologia Applicata|
|Data di pubblicazione:||25-mag-2020|
|Digital Object Identifier (DOI):||http://dx.doi.org/10.3390/ijms21103715|
|Appare nelle tipologie:||01 - Articolo su periodico|